Polypoidal Choroidal Vasculopathy (PCV): Clinical Trials

1 trial for Polypoidal Choroidal Vasculopathy (PCV), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Polypoidal Choroidal Vasculopathy (PCV): new trials by email Literature Review of Polypoidal Choroidal Vasculopathy (PCV) trials Research Report on Polypoidal Choroidal Vasculopathy (PCV)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)
Conbercept - Polypoidal Choroidal Vasculopathy (PCV)
Phase 4UnknownChengdu Kanghong Biotech Co., Ltd.3002015-10-012017-07-19

Narrower conditions

Polypoidal Choroidal Vasculopathy (1)

Broader conditions

Choroid Diseases (1)  ·  Choroidal Neovascularization (1)  ·  Eye Diseases (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Uveal Diseases (1)

Interventions

KH902 fusion protein (1)

Sponsors

Chengdu Kanghong Biotech Co., Ltd. (1)

Countries

China (1)